The Salk Institute is currently closed to the public. The Institute continues to monitor the status of the pandemic and expects to reopen the Salk campus at a later date. Please check back for updates.
LA JOLLA—The Salk Institute, along with Sanford Burnham Prebys, have signed an exclusive licensing agreement with California-based Endeavor BioMedicines for an intellectual property portfolio relating to cancer therapeutics and diagnostics that target ULK1/2, a protein involved in cellular recycling, jointly developed by researchers at Salk and Sanford Burnham Prebys. The negotiations were led by the Salk Office of Technology Development and the Sanford Burnham Prebys Business Development Office.
LA JOLLA—Researchers at the Salk Institute’s Harnessing Plants Initiative (HPI) have established a five-year, $6.2 million collaboration with Nadia Shakoor, principal investigator and senior research scientist and her team at the Donald Danforth Plant Science Center to identify and develop sorghum plants that can better capture and store atmospheric carbon.
LA JOLLA—When people think about the connection between genes and disease, they often envision something that works like a light switch: When the gene is normal, the person carrying it does not have the disease. If it gets mutated, a switch is flipped, and then they do have it.
LA JOLLA—The Salk Institute announced today that philanthropic donors gave more than $100 million to support bold scientific research in fiscal year 2021 (ending in June). The amount is a new record in philanthropic gifts for the Institute, eclipsing the previous record gift total in 2019 by more than $11 million.
LA JOLLA—Salk Associate Professor Axel Nimmerjahn is leading a research team that has been awarded $11.2 million by The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, an effort that aims to investigate overarching principles of brain circuit function, including sensation, perception, decision-making and motor control. Nimmerjahn will lead an interdisciplinary five-year project investigating how astrocytes, star-shaped cells in the brain, process and modulate signals from neurons to better understand overall brain function.
LA JOLLA—Professor Janelle Ayres has been recognized for her contributions and dedication to advancing science through research by being named the inaugural recipient of the Salk Institute Legacy Chair, effective July 1, 2021.
LA JOLLA—The Salk Institute has promoted Diana Hargreaves to the rank of associate professor for her notable contributions in epigenetic regulation, which make specific regions of our DNA accessible to the machinery of cells. The promotion was based on recommendations by Salk faculty and nonresident fellows, and approved by President Rusty Gage and the Institute’s Board of Trustees.
LA JOLLA—Time-restricted eating (TRE), a dietary regimen that restricts eating to specific hours, has garnered increased attention in weight-loss circles. A new study by Salk scientists further shows that TRE confers multiple health benefits besides weight loss. The study also shows that these benefits may depend on sex and age.
LA JOLLA—The Salk Institute’s Education Outreach program has received the 2021 Inspiring Programs in STEM Award from INSIGHT Into Diversity magazine, the largest and oldest diversity and inclusion publication in higher education. The Inspiring Programs in STEM Award honors colleges and universities that encourage and assist students from underrepresented groups to enter the fields of science, technology, engineering and mathematics (STEM). Salk will be featured, along with 78 other recipients, in the September 2021 issue of INSIGHT Into Diversity magazine.
LA JOLLA—It’s long been known that opioid overdose deaths are caused by disrupted breathing, but the actual mechanism by which these drugs suppress respiration was not understood. Now, a new study by Salk scientists has identified a group of neurons in the brainstem that plays a key role in this process.
LA JOLLA—A Salk Institute team led by Professor Satchin Panda, along with teams from five other organizations, have been awarded a total of $220 million by the Joe and Clara Tsai Foundation’s Human Performance Alliance, whose philanthropic investment aims to transform human health on a global scale through the discovery and translation of the biological principles underlying human performance.
LA JOLLA—Salk Professor Kay Tye has been named one of three winners of the prestigious Blavatnik National Awards for Young Scientists, one of the world’s largest unrestricted prizes for early-career researchers. Tye, the laureate in the Life Sciences category, will receive $250,000 for her trailblazing work in studying the neural circuits and behaviors related to anxiety and social interaction.
LA JOLLA—Scientists—and gardeners—have long known that plants grow taller and flower sooner when they are shaded by close-growing neighbors. Now, for the first time, researchers at the Salk Institute have shown the detailed inner workings of this process.
It is with heartfelt sorrow that we inform you of the death of a member of the Salk community, Swati Tyagi, PhD. Swati, a postdoctoral researcher in the Hetzer lab, was tragically killed yesterday when a person in a car struck her from behind while she was riding her bike. We offer our deepest condolences to her family, friends and coworkers at this difficult time.
LA JOLLA—When looking at a complex landscape, the eye needs to focus in on important details without losing the big picture—a charging lion in a jungle, for example. Now, a new study by Salk scientists shows how inhibitory neurons play a critical role in this process.
LA JOLLA—(June 15, 2021) For the tenth consecutive time, the Salk Institute has earned the highest ranking—4 out of 4 stars—from Charity Navigator, America’s largest independent charity and nonprofit evaluator. Only three percent of the roughly 10,000 nonprofits evaluated have achieved this recognition ten consecutive times. The coveted ranking indicates the Salk Institute has demonstrated strong financial health and commitment to accountability and transparency, outperforming most other charities in America in regard to executing best fiscal practices and carrying out its mission in a financially efficient way.
LA JOLLA—In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech have found that the environment inside tumors (the tumor microenvironment) contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their ability to kill cancer cells. In a vicious cycle, those T cells, in need of energy, increase the level of a cellular fat transporter, CD36, that unfortunately saturates them with even more oxidized fat and further curtails their anti-tumor functions.
LA JOLLA—Type 1 diabetes, which arises when the pancreas doesn’t create enough insulin to control levels of glucose in the blood, is a disease that currently has no cure and is difficult for most patients to manage. Scientists at the Salk Institute are developing a promising approach for treating it: using stem cells to create insulin-producing cells (called beta cells) that could replace nonfunctional pancreatic cells.